Search For "n k arora"
India's COVID-19 tally not rising due to hybrid immunity -Top Health Exper
Updated : 3 years, 5 months ago IST
Despite South Asian countries reporting an increase in COVID-19 cases, India is not getting affected because of hybrid immunization, said COVID-19 Working Group NTAGI Chairman N K Arora on Wednesday.
Read More
INSACOG plans to increase sites for sewage sample collection for COVID-19,
Updated : 4 years, 1 month ago IST
New Delhi [India], April 11 (ANI): The Indian SARS Cov2 genomic consortium (INSACOG) is looking into the results of samples collected from 15 states and 19 sewage sites for COVID-19 and plans to increase more sites for sewage sample collection, said NTAGI Chairman Dr N K Arora on Monday.
Read More
COVID-19 variants will keep on occurring, nothing to panic about, says Dr
Updated : 4 years, 1 month ago IST
New Delhi [India], April 11 (ANI): New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India, National Technical Advisory Group on Immunisation (NTAGI), Dr NK Aror
Read More
Corbevax COVID vaccine is safe, offers high antibody levels: NTAGI chief
Updated : 4 years, 3 months ago IST
New Delhi [India], February 15 (ANI): India's third homegrown COVID-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Dr N K Arora, Chairman, India's COVID-19 Working group of National Technical Advisory Group on immun
Read More
Policy on booster, additional COVID-19 vaccine doses in two weeks, says Dr
Updated : 4 years, 6 months ago IST
New Delhi [India], November 29 (ANI): With the emergency of new COVID-19 variant 'Omicron', COVID-19 task force chairman Dr N K Arora said that a comprehensive policy on the booster and additional doses of COVID-19 vaccine will be announced in two weeks.
Read More
COVID appropriate behaviour important during festive season, says NTAGI ch
Updated : 4 years, 8 months ago IST
Mumbai (Maharashtra) [India], September 9 (ANI): Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr N K Arora said that COVID appropriate behaviour is very important to follow, during the forthcoming festive season.
Read More
Initial hiccups in Bharat Biotech Banglaore plant delayed Covaxin producti
Updated : 4 years, 10 months ago IST
New Delhi [India], August 2 (ANI): India achieved the target of 47 crore COVID-19 vaccine doses till the month of July, Dr N K Arora, Chief of National Immunization Technical Advisory Group (NTAGI) said and added that some hiccups like initial difficulties in the new Bangalore plant of Bhara
Read More
Current vaccines effective against COVID-19 Delta variant as per ICMR stud
Updated : 4 years, 10 months ago IST
New Delhi [India], July 19 (ANI): The current vaccines available in India are effective against the COVID-19 Delta variant as per the studies done by the Indian Council of Medical Research (ICMR), says Dr N K Arora, co-chair, Indian SARS-CoV-2 Genomics Consortium (INSACOG).
Read More
Zydus Cadila COVID-19 vaccine for children above 12 yrs expected by August
Updated : 4 years, 11 months ago IST
New Delhi [India], June 27 (ANI): Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, said Dr N K Arora, Chairman, National Technical Advisory Group on Immunisation (NTAGI).
Read More
There is no dissent on increasing gap between doses of Covid-19 vaccine Co
Updated : 4 years, 11 months ago IST
New Delhi [India], June 16 (ANI): Chairman of the National Technical Advisory Group on Immunisation (NTAGI) on Wednesday refuted reports that there was dissent among experts within the scientific group about extending the intervals between the two doses of the Covid-19 vaccine Covishield to
Read More
COVID-19: India's new vaccine plan to study mixing doses
Updated : 5 years ago IST
New Delhi [India], May 31 (ANI): Amid a shortage of vaccines, India plans to do a study on mixing COVID-19 doses and to ascertain its efficacy in boosting the immune response to coronavirus.
Read More
Bharat Biotech to ramp up production of Covaxin to 10-12 crore doses by Ju
Updated : 5 years ago IST
New Delhi [India], May 31 (ANI): With ramping up of production capacities, nearly 25 crore ‘Made in India’ vaccine doses are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore peopl
Read More